Argentina Analysis

Pages

Industry Trend Analysis - Intellectual Property Risks Will Limit Opportunities For Innovative Drugmakers - MAY 2015

A lack of transparency for data protection and import trade, compounded with worsening patent restrictions will ensure Argentina's appeal to foreign pharmaceutical companies in 2015 is limited. The country's troubling intellectual property regime will be particularly concerning for innovative drugmakers as the adequacy of Argentina's patent law remains questionable.

READ FULL ARTICLE

Industry Trend Analysis - Government Postpones Drug Price Cuts - APR 2014

The Argentine government's intervention in pharmaceutical pricing, particularly repeated price freezes, is both heavy handed and apparently open-ended. We have previously highlighted Argentina's highly challenging environment for pharmaceutical companies,, due to the anticipated future currency devaluation, high inflation and nationalisation approaches.[1]

READ FULL ARTICLE

Pages